Microwave-promoted, catalyst-free, multi-component reaction of proline, aldehyde, 1,3-diketone: one pot synthesis of pyrrolizidines and pyrrolizinones
摘要:
One-pot, three-component preparation of the pyrrolizidine and pyrrolizinone derivatives in moderate to good yield is reported. The synthesis is facilitated by microwave irradiation of proline, aromatic aldehyde, and 1,3-diketone such as 2-arylmethylene-indene-1,3-dione and 4-hydroxycoumarin in 1,4-dioxane or xylene. This method provides a quick access to the multi-functionalized pyrrolizidines and pyrrolizinones. (C) 2015 Elsevier Ltd. All rights reserved.
Microwave-promoted, catalyst-free, multi-component reaction of proline, aldehyde, 1,3-diketone: one pot synthesis of pyrrolizidines and pyrrolizinones
摘要:
One-pot, three-component preparation of the pyrrolizidine and pyrrolizinone derivatives in moderate to good yield is reported. The synthesis is facilitated by microwave irradiation of proline, aromatic aldehyde, and 1,3-diketone such as 2-arylmethylene-indene-1,3-dione and 4-hydroxycoumarin in 1,4-dioxane or xylene. This method provides a quick access to the multi-functionalized pyrrolizidines and pyrrolizinones. (C) 2015 Elsevier Ltd. All rights reserved.
Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
申请人:Ansorge Siegfried
公开号:US20070037752A1
公开(公告)日:2007-02-15
The invention relates to substances which specifically inhibit peptidases splitting ala-p-nitroanilide for use in medicine. The invention further relates to the use of at least one such substance or of a pharmaceutical or cosmetic composition containing at least one such substance for the prophylaxis and therapy of diseases, in particular the prophylaxis and therapy of diseases with an overshooting immune response (autoimmune diseases, allergies and transplant rejections), of other chronic inflammatory diseases, neuronal diseases and brain damages, skin diseases (acne and psoriasis, among others), tumor diseases and special virus infections (including SARS).